HOME >> MEDICINE >> NEWS
One in five asthmatics are highly sensitive to aspirin

One in five asthmatic patients are sensitive to aspirin, yet many are unaware that they are at risk of a potentially life threatening reaction known as aspirin induced asthma, warn researchers in this week's BMJ.

Aspirin induced asthma is a severe reaction to aspirin and other commonly used painkillers, but controversy exists over its prevalence.

Researchers analysed 21 studies of asthmatic patients and found the prevalence of aspirin induced asthma to be 21% in adults and 5% in children.

Most of these patients were also sensitive to over the counter non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen, and diclofenac, but only 7% of them were sensitive to paracetamol.

Since aspirin and NSAIDs are often self prescribed, patients diagnosed with asthma should be alerted to the possibility of aspirin induced asthma by their healthcare professional, say the authors.

They recommend including simple, standardised warnings on packs of aspirin and NSAIDs, alerting asthmatic patients to the potential risks.


'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
19-Feb-2004


Page: 1

Related medicine news :

1. Study proves flu shot safe for asthmatics
2. Physicians miss opportunities to improve care for oldest asthmatics
3. New highly active agents against sandfly fever
4. Engineers develop biowarfare sensing elements for future highly sensitive nerve-gas detectors
5. Patients with cancer have highly increased risk for blood clots
6. Inflammatory cells highly promising target in NF 1
7. Multi-center study finds therapy boosts kidney transplants in highly sensitized patients
8. Columbia Univ. Medical Center wins highly competitive stroke grant from NIH
9. Study showed vitamin D inadequacy highly prevalent among women treated for osteoporosis
10. World mental health surveys find mental disorders highly prevalent and often untreated
11. MRI highly useful in the evaluation of patients with uterine fibroids

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: One five asthmatics are highly sensitive aspirin

(Date:5/23/2013)... 23, 2013 Visage Imaging Inc., a ... PME), announced today that they have released Visage ... App Store*. When used in tandem with the ... authorized healthcare providers simple mobile access to imaging results ... In addition to numerous enhancements and performance improvements, Visage ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Fresh Healthy ... vending machines stocked with healthy food and drinks in ... The company’s in-house, full-service marketing and advertising department has ... in the media for their franchisees, and to promote ... has been featured in many leading publications and TV ...
(Date:5/23/2013)... 23, 2013 Dimensional Insight, a ... announced today that Paul Comras, director of ... at the 2013 International Medical Users Software Exchange ... & Revenue Visibility from Your General Ledger.” The ... from 2:30-3:25 p.m. in Azalea 1 at the ...
(Date:5/23/2013)... May 23, 2013 NDI Medical, ... and develops innovative neurodevice technologies, has launched its ... DBI will commercialize its groundbreaking technology that ... therapy for patients with Parkinson’s disease. Currently ... disease and generates more than $275 million in ...
(Date:5/23/2013)... 2013 A medical malpractice case which ... number 110504/2009) by Lori Mandel, an office manager in ... $8.6 million. Ms. Mandel sought the medical expertise of ... further complications that affected the quality of her life ... plaintiff alleged that her doctor rendered conservative treatment for ...
Breaking Medicine News(10 mins):Health News:Mobile Imaging Access Leaps Ahead with Visage Ease 2Health News:Mobile Imaging Access Leaps Ahead with Visage Ease 3Health News:Fresh Healthy Vending Receives Recent National and Local Media Focus 2Health News:Dimensional Insight to Demonstrate How Hospitals Can Use Business Intelligence within MEDITECH Environments at 2013 International MUSE Conference 2Health News:NDI Launches Deep Brain Innovations, LLC 2Health News:NDI Launches Deep Brain Innovations, LLC 3Health News:New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury 2Health News:New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury 3
(Date:5/23/2013)... NEW YORK , May 23, 2013  Echo ... has committed to waive down the Acceptance Threshold from ... Affected plus one Elan Share in accordance with the ... to the conditions summarized below. Under the ... to acquire Elan (NYSE: ELN ) for ...
(Date:5/23/2013)... , Engeland, May 23, 2013 ... voor mannen met lagere urinewegsymptomen geassocieerd met BPH ... de Europese dochteronderneming van Astellas Pharma Inc, gebaseerd in ... : 4503), kondigde vandaag aan dat het Nederlandse College ... voor VESOMNI in Nederland. De handelsvergunning verleend ...
(Date:5/22/2013)... Advanced Prenatal Therapeutics (APT), a privately held ... alleviate the high blood pressure and other symptoms associated ... be the first medical device specifically designed to treat ... Every year, preeclampsia affects approximately 300,000 pregnant ... It is characterized by high blood pressure and proteinuria ...
Breaking Medicine Technology:Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 2Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 3Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 4Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2
Cached News: